慢性肾脏病与经导管主动脉瓣植入术患者结局的关联
该研究基于德国2010年1月1日至2013年12月31日所有住院接受经导管主动脉瓣植入术的患者数据,评估慢性肾脏病(CKD)对住院结局和费用的影响。共28,716例患者,其中11,189例(39.0%)患有CKD。CKD与住院死亡率、出血和急性肾损伤独立相关,但CKD 4期和5期患者卒中风险较低。
要点
- CKD 3期及以上与住院死亡率独立相关(最高OR 1.71)。
- CKD 4期及以上与出血独立相关(最高OR 1.82)。
- CKD 3期和4期与急性肾损伤独立相关(OR分别为1.83和2.33)。
核心结论
- 该分析首次在全国范围内说明CKD与经导管主动脉瓣植入术患者不良结局相关,术前CKD分期对风险分层重要。
研究设计与样本
- 基于德国2010年1月1日至2013年12月31日所有住院接受经导管主动脉瓣植入术患者的全国性数据分析,共28,716例。
主要发现
- 11,189例(39.0%)患有CKD;CKD患者以女性为主,合并症如冠状动脉疾病、纽约心脏协会3/4级心力衰竭、外周动脉疾病和糖尿病比例更高,估计逻辑欧洲心脏手术风险评估系统值高1.3倍。
- 住院死亡率与CKD 3期及以上独立相关(最高OR 1.71,95%CI 1.35-2.17,P<0.05)。
- 出血与CKD 4期及以上独立相关(最高OR 1.82,95%CI 1.47-2.24,P<0.001)。
- 急性肾损伤与CKD 3期(OR 1.83,95%CI 1.62-2.06)和4期(OR 2.33,95%CI 1.92-2.83)独立相关(均P<0.001)。
- 卒中风险在CKD 4期(OR 0.23,95%CI 0.16-0.33)和5期(OR 0.24,95%CI 0.15-0.39)患者中较低(均P<0.001);CKD患者平均住院时间延长1.2倍,报销费用平均仅高1.03倍。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Despitethe multiple depicted associations of CKD with reduced cardiovascular and overall prognoses, the association of CKD with outcome of patients undergoing transcatheter aortic valve implantation has still not been well described. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Data from all hospitalized patients who underwent transcatheter aortic valve implantation procedures between January 1, 2010 and December 31, 2013 in Germany were evaluated regarding influence of CKD, even in the earlier stages, on morbidity, in-hospital outcomes, and costs. RESULTS: A total of 28,716 patients were treated with transcatheter aortic valve implantation. A total of 11,189 (39.0%) suffered from CKD. Patients with CKD were predominantly women; had higher rates of comorbidities, such as coronary artery disease, heart failure at New York Heart Association 3/4, peripheral artery disease, and diabetes; and had a 1.3-fold higher estimated logistic European System for Cardiac Operative Risk Evaluation value. In-hospital mortality was independently associated with CKD stage ≥3 (up to odds ratio, 1.71; 95% confidence interval, 1.35 to 2.17; P<0.05), bleeding was independently associated with CKD stage ≥4 (up to odds ratio, 1.82; 95% confidence interval, 1.47 to 2.24; P<0.001), and AKI was independently associated with CKD stages 3 (odds ratio, 1.83; 95% confidence interval, 1.62 to 2.06) and 4 (odds ratio, 2.33; 95% confidence interval, 1.92 to 2.83 both P<0.001). The stroke risk, in contrast, was lower for patients with CKD stages 4 (odds ratio, 0.23; 95% confidence interval, 0.16 to 0.33) and 5 (odds ratio, 0.24; 95% confidence interval, 0.15 to 0.39; both P<0.001). Lengths of hospital stay were, on average, 1.2-fold longer, whereas reimbursements were, on average, only 1.03-fold higher in patients who suffered from CKD. CONCLUSIONS: This analysis illustrates for the first time on a nationwide basis the association of CKD with adverse outcomes in patients who underwent transcatheter aortic valve implantation. Thus, classification of CKD stages before transcatheter aortic valve implantation is important for appropriate risk stratification.
引用
- Lüders F, Kaier K, Kaleschke G, et al. Association of CKD with Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation. Clin J Am Soc Nephrol. 2017. PMID: 28289067. doi:10.2215/CJN.10471016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。